On this issue, one decision maker stated that the PHSA has taken "a whole bunch of agencies and put them together, and all their budgets together with them".
Decision makers stated that setting priorities in this context can be quite difficult and that they do not feel they have the right tools to inform such decisions.
Decision makers stated that there had been little discussion of resource re-allocation across PHSA agencies, with each agency by and large operating as its own entity.
However, public health decision makers state that finding and accessing systematic reviews related to public health continues to be a barrier to evidence-informed public health practice [ 11- 16].
This is confirmed by studies such as that of Drummond et al. [ 10– 12], which revealed that, in the UK, 30% of local decision makers state that being unable to take a long-run view, due to the importance of their annual budget, is an important obstacle to the use of economic evaluations.
In a qualitative study by Dobbins et al. public health decision-makers stated their need for assistance managing the vast quantities of evidence [ 2].
Importantly, most respondents were the final decision-makers, stating that they were either the 'overall final decision maker', or that trial site selection decisions were 'entirely at (their) discretion'.
One decision-maker stated, "I think the fact that we have such a strong basic and translational research infrastructure within many of our health care organizations within the PHSA is a real strength".
In Table 5, the decision maker indicates states of the null by examining a small sample of the population and consequently accepting or rejecting the null hypothesis.
There are 51 decision makers (50 states plus the District of Columbia) and a total of 10 decisions, resulting in a data matrix (B=[b_{ij}]_{51 times10}) where b_{ij}= textstylebegin{cases} 1 & text{if state $i$ voted for the winner of election $j$}, 0 & text{otherwise}.
